Bueno, Renata Vieria; Braga, Rodolpho de Campos; Segretti, Natanael Dante; Ferreira, Elizabeth Igne 
; Trossini, Gustavo Henrique Goulart ; Andrade, Carolina Horta
Source: Current Pharmaceutical Design. Unidade: FCF
Subjects: TUBERCULOSE, ÁCIDOS NUCLEICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Renata Vieria et al. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, v. 20, n. 27, p. 4474-4485, 2014Tradução . . Acesso em: 09 nov. 2024.APA
Bueno, R. V., Braga, R. de C., Segretti, N. D., Ferreira, E. I., Trossini, G. H. G., & Andrade, C. H. (2014). New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design, 20( 27), 4474-4485.NLM
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2024 nov. 09 ]Vancouver
Bueno RV, Braga R de C, Segretti ND, Ferreira EI, Trossini GHG, Andrade CH. New tuberculostatic agents targeting nucleic acid biosynthesis: drug design using QSAR approaches. Current Pharmaceutical Design. 2014 ; 20( 27): 4474-4485.[citado 2024 nov. 09 ]
